1. Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas
   D. Pérez-Callejo et al, 2015, Cancer Treatment Reviews CrossRef
2. Potential therapeutic effects of curcumin in gastric cancer
   Nastaran Barati et al, 2019, Journal of Cellular Physiology CrossRef
3. Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein–Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma
   Si‐Wei Li et al, 2013, Head & Neck CrossRef
4. An update on newer monoclonal antibodies in lymphoma therapy
   Subhashini Archana Kadavakolan et al, 2016, Asian Journal of Oncology CrossRef
5. RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer
   null Gabriela-Freitas et al, 2019, Biomolecules CrossRef
6. RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity
   Roni Touboul et al, 2021, Cancers CrossRef
7. Targeting Raf Kinase Inhibitory Protein Regulation and Function
   Ali Yesilkanal et al, 2018, Cancers CrossRef
8. New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances
   Carolina Simioni et al, 2020, Hematological Oncology CrossRef
9. Mechanisms of resistance to anti-CD20 antibodies in lymphoid malignancies
   Anne Bordron et al, 2024, Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal CrossRef
10. Combinatorial Chemotherapeutic Efficacy in Non-Hodgkin Lymphoma Can Be Predicted by a Signaling Model of CD20 Pharmacodynamics
    John M. Harrold et al, 2012, Cancer Research CrossRef
11. RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
    Apostolos Zaravinos et al, 2018, Cancers CrossRef